drugset / Trial / NCT00235625

Curcuminoids for the Treatment of Chronic Psoriasis Vulgaris

NCT00235625 ↗

Phase 2 Completed 12 enrolled University of Pennsylvania
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Turmeric (Curcuma Longa) is member of the ginger family and is best known for its culinary use as the major of component of curry powder. The volatile of oils (called curcuminoids) of the turmeric root, however, have anti-inflammatory actions which make them promising candidates for the treatment of psoriasis. For example, curcumin has been shown to improve psoriasis in experiments using in vitro models. Turmeric has been shown to have minimal side effects in doses up to 12 grams per day. The purpose of this study is to determine the safety and to estimate the efficacy of oral Curcuminoid C3 Complex® in patients with chronic psoriasis vulgaris.

Timeline

Start
2005-10
Primary completion
—
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Curcuminoids C3 Complex® Unknown — Oral

Indications